MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.29, sa.3, ss.98-104, 2020 (ESCI İndekslerine Giren Dergi)
Objectives: In this study, we aimed to investigate whether Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scanning is adequate to predict intermediate risk, high risk, or oligometastatic prostate cancer (PCa) as an initial staging modality.